本页面由Tiger Trade Technology Pte. Ltd.提供服务

X4制药

2.60
-0.2200-7.80%
盘后:2.620.0200+0.77%19:30 EDT
成交量:43.96万
成交额:117.16万
市值:2.58亿
市盈率:-2.93
高:2.83
开:2.81
低:2.59
收:2.82
52周最高:4.83
52周最低:2.59
股本:9,914.67万
流通股本:6,235.43万
量比:0.77
换手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):-0.8867
每股收益(LYR):-1.8726
净资产收益率:-113.08%
总资产收益率:-28.15%
市净率:1.66
市盈率(LYR):-1.39

数据加载中...

2022/08/03

SEC问询函

CORRESP [Cover] - Correspondence
2022/07/29

重要事件披露

8-K - Current report
2022/07/19

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/01

重要事件披露

8-K - Current report
2022/06/07

重要事件披露

8-K - Current report
2022/05/20

重要事件披露

8-K - Current report
2022/05/12

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report
2022/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/17

重要事件披露

8-K - Current report
2022/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/03

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals